Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic
  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

The Inevitable Resurgence of CBD Stocks (NASDAQ: NEPT) (OTC US: GRPS) (NYSE AMERICAN: YCBD)

By: OTC

The CBD theme is tied closely to the cannabis theme. But there is a distinction. First off, CBD is already legal in all 50 states. The upside potential for the CBD industry is also thought to be considerably higher than that of the THC-bearing cannabis-based products industry because it has a greater potential to translate into the mainstream consumer products sector.

CBD products are not about “getting high”. They’re about “getting well”. There is an increasing body of research that suggests CBD products may function as a key health and wellness supplement. And this idea has already caught on with a growing number of consumers interested in preventative health and wellness.

According to Grand View Research, the global cannabidiol market size is expected to reach $13.4 billion by 2028. The market is expected to expand at a CAGR of 21.2% from 2021 to 2028. The study notes that “Increasing awareness about the health benefits of cannabidiol (CBD), changing consumer opinion, and attitude toward CBD products are some of the key factors driving the demand for these products. Furthermore, increasing demand for cannabidiol from various end-user industries such as food and beverage, personal care and cosmetics, and pharmaceuticals is expected to trigger market growth.”

With that in mind, we take a look at a few of the more active and interesting stocks with direct exposure to theme, including: Neptune Wellness Solutions Inc (NASDAQ:NEPT), Gold River Productions Inc (OTCMKTS:GRPS), and cbdMD Inc (NYSEAMERICAN:YCBD).

 

Neptune Wellness Solutions Inc (NASDAQ:NEPT) operates through two segments, Nutraceutical and Cannabis. The Nutraceutical segment offers turnkey solutions, such as raw material sourcing, formulation, quality control, and quality assurance for omega-3 and hemp-derived ingredients under different delivery forms, including softgels, capsules, and liquids. The Cannabis segment provides extraction and purification services from cannabis and hemp biomass.

The company also offers formulation and manufacturing solutions for value added product forms, such as tinctures, sprays, topicals, vapor products, edibles, and beverages.

Neptune Wellness Solutions Inc (NASDAQ:NEPT) just announced the filing of a preliminary short form base shelf prospectus, which provides the flexibility to make offerings of securities during the effective period of the Prospectus, until April 2023. The final short form base shelf prospectus is expected to be filed in April 2021 and will replace the existing shelf prospectus, which was filed in January 2019.

According to the release, the Prospectus has been filed in each of the provinces and territories of Canada, and a corresponding shelf registration statement on Form F-10 was also filed with the United States Securities and Exchange Commission. These filings, when made final and effective, will enable offerings of securities up to an aggregate initial offering price of US$250 million at any time during the 25-month period that the Prospectus remains effective.

While this is a clear factor, it has been incorporated into a trading tape characterized by a pretty dominant offer, which hasn’t been the type of action NEPT shareholders really want to see. In total, over the past five days, shares of the stock have dropped by roughly -6% on above average trading volume. All in all, not a particularly friendly tape, but one that may ultimately present some new opportunities. Over the past month, shares of the stock have suffered from clear selling pressure, dropping by roughly -6%.

Neptune Wellness Solutions Inc (NASDAQ:NEPT) generated sales of $3.3M, according to information released in the company’s most recent quarterly financial report. That adds up to a sequential quarter-over-quarter growth rate of -88.4% on the top line. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($32.2M against $19.1M).

 

Gold River Productions Inc (OTCMKTS:GRPS) trumpets itself as a company focused on market-targeted products including, but not limited to rare cannabinoids and effective products where a particular need is identified.

Products for pain relief, sleep, etc. that will be distributed through convenience stores, independent pharmacies and more will have mass appeal to the market.

Gold River Productions Inc (OTCMKTS:GRPS) most recently announced the appointment of the Dr. Bruce Bond in this integral role of the company.

According to the company’s release, Dr. Bond practiced for twenty-two years and the Company will be utilizing his vast experience in clinical practice along with his experience in the nutraceutical industry, which includes eighteen years as a nutritional and marketing consultant for Standard Process, where he contributed as a national speaker for that period as well. With almost 500 national lectures, he spoke on the topics of endocrinology, cardiology, hepatic dysfunction, immune disorders and more with regards to nutraceutical, whole foods and herbal therapy. In his capacity, he introduced and trained physicians in the science of nutraceuticals and herbs as alternatives to traditional pharmacologic medicine. Dr. Bond provided developmental input on many new products that afforded Standard Process immense national and international success. His landmark book, published in 2013, “Practicing with Integrity and Excellence, How to Take Your Practice from Good to Great,” sets a new standard for the incorporation of nutraceuticals into traditional medical, chiropractic, osteopathic, acupuncture, and naturopathic practices.

GRPS has pulled back over the past week of trading action, with shares sinking something like -12% in that time. That said, the stock has been on a rip-roaring upward trend, up over 600% since December.

Gold River Productions Inc (OTCMKTS:GRPS) generated sales of $937K, according to information released in the company’s most recent quarterly financial report. That adds up to a huge sequential quarter-over-quarter growth rate of 41.9% on the top line.

 

cbdMD Inc (NYSEAMERICAN:YCBD) promulgates itself as a company that produces and distributes various cannibidiol (CBD) products. It owns and operates the consumer hemp-based CBD brand, cbdMD. The company’s product categories include CBD tinctures, capsules, gummies, bath bombs, topical creams, and animal treats and oils. It also offers pet related CBD products under the Paw CBD brand name.

The company distributes its products through an e-commerce Website, wholesalers, and various brick and mortar retailers in the United States.

cbdMD Inc (NYSEAMERICAN:YCBD) just announced that it has formed cbdMD Therapeutics LLC, a newly formed wholly-owned subsidiary of the Company for the purposes of isolating and quantifying the Company’s ongoing investments in science related to its existing and future products, including research and development activities for therapeutic applications.

“As one of the leading consumer CBD brands in the world, I believe cbdMD is in a unique position to explore the therapeutic potential of CBD and the other lesser-known cannabinoids, support scientific advancements through clinical trials, and perform toxicity studies to demonstrate the safety of cannabinoids as novel therapies. The Company has formed cbdMD Therapeutics with the mission to provide its customers with therapeutic options to replace opioids and other prescription pain killers and bring to market novel therapies for conditions where people suffer from pain, inflammation, sleeplessness or anxiety such as osteoarthritis, fibromyalgia, insomnia, and anxiety disorders. These novel therapies will be first identified through the core of cbdMD’s current dietary supplement science and research to further expand its brand’s use and acceptance by consumers worldwide. The launch of the cbdMD Therapeutics signals to the marketplace that cbdMD is committed to providing the necessary resources to ensure the success of this mission,” said Dr. Swift.

The stock has suffered a bit of late, with shares of YCBD taking a hit in recent action, down about -7% over the past week.

cbdMD Inc (NYSEAMERICAN:YCBD) generated sales of $12.3M, according to information released in the company’s most recent quarterly financial report. That adds up to a sequential quarter-over-quarter growth rate of 5.4% on the top line. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($29M against $6.7M).

DISCLAIMER:  EDM Media LLC (EDM), is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  EDM is NOT affiliated in any manner with any company mentioned herein.  EDM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  EDM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  EDM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed EDM has been compensated seven hundred fifty dollars for news coverage of the current press releases issued by Gold River Productions Inc by a third party.

EDM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and EDM undertakes no obligation to update such statements.

 

 

 

 

 

 

Media Contact:

EDM Media LLC

Email: IR@EDM.Media

Office: 800-301-7883

EDM.Media

 

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.